Contents
Contents
Medical device Stark law cases follow the money between the physician choosing an implant and the hospital billing Medicare. The Stark Law bars physicians from referring patients for designated health services to a provider with which they or an immediate family member have a financial relationship, unless an exception applies. It also bars the provider from billing Medicare for those referrals.
For someone inside a device company or hospital, the connection can run through an implant distributorship, a compensation agreement or a hospital investment. A surgeon can choose the implant while the hospital buys it and bills for the care. The financial arrangement shows who else benefits from that decision.
Medicare generally pays for an implanted device within the hospital stay or procedure payment. The hospital purchases the product, while the physician may make or strongly influence the choice of brand and type. The Department of Health and Human Services Office of Inspector General’s alert on physician-owned entities identifies this feature of the market: implants are physician preference items. The person choosing the product can have considerable influence over someone else’s purchasing budget.
Consignment makes the connection especially close. A manufacturer may retain ownership of inventory stored at the hospital until an implant is used. The clinical event can therefore trigger the sale. The representative handling the implant trays may also manage inventory and replenishment, connecting the surgeon’s choice to the product the hospital purchases.
The Senate Finance Committee minority staff’s examination of device distribution describes representatives ordering, delivering, stocking and supporting instrumentation in the operating room. The preference, the inventory movement and the purchase each leave a different part of the transaction visible.
Medicare’s inpatient system pays predetermined amounts for a discharge based on the patient’s assigned payment group. Its outpatient system pays according to the service classification. The Centers for Medicare & Medicaid Services describes both in its cardiac-device billing guidance. The implant’s cost usually sits inside that facility payment.
Designated health services are the categories covered by the physician self-referral law. Inpatient and outpatient hospital services are on the Centers for Medicare & Medicaid Services’ list, alongside durable medical equipment, prosthetics, orthotics and related supplies.
For an implant used during hospital care, the hospital service is central to the inquiry. The agency identifies the provider through who performs the services or submits the Medicare claim. That directs attention to the hospital’s relationship with the referring physician and the services billed. A manufacturer or distributor may appear elsewhere in the financial chain.
A referral can include an order or a plan of care that calls for designated health services. We connect that clinical decision to the provider, the financial relationship and the claim. The device brand identifies what was selected. The hospital records establish where the selection became care billed to Medicare.
We identify the service Medicare paid for and the physician’s connection to the entity furnishing it. That keeps the financial relationship attached to an actual claim.
Kickbacks divert decisions about patient care toward the financial benefit of the people making or influencing them. Patients lose independent medical judgment, and taxpayers pay for care shaped by the seller’s return. The Anti-Kickback Statute prohibits knowingly and willfully paying or receiving value to induce referrals, purchases or recommendations involving items or services paid for by federal health care programs, including Medicare and Medicaid. In devices, that reaches the money behind product selection, including payments from manufacturers and distributors.
The Stark Law focuses on a physician’s referral for designated health services to a financially connected provider. Hospital insiders can encounter both laws in the same arrangement, as the OASIS settlement below illustrates.
Ownership and compensation connect physicians to the business in different ways. An ownership interest gives the physician a stake in the entity. Compensation can take the form of employment pay, consulting fees, rent or another payment arrangement. The relationship may involve the physician’s immediate family and may run directly to the hospital or through other businesses.
A hospital purchase from a physician-owned distributor can create an indirect financial link to the surgeon. We examine who owns each business, which entity pays which, how the physician’s return is calculated and what the hospital knew about that return.
Our page on physician-owned distributor fraud examines how surgeons can earn from implants they choose for their own patients.
Employment, personal service arrangements such as consulting, and office or equipment rentals have Stark exceptions with conditions on fair market value and payments tied to referrals. Hospital ownership has a separate exception for a stake in the entire hospital, subject to additional restrictions on physician-owned hospitals.
Device kickback allegations include consulting payments, royalties, distributor profits, practice support, advertising and benefits routed through a physician’s other business. The hospital cases add investment opportunities and financing payments to referring groups. The following matters show different parts of that relationship: the implant sale, the physician’s return and the hospital’s claim.
Sanford Health agreed to a $20.25 million federal settlement in October 2019 over alleged kickbacks and unnecessary spinal surgeries. The government alleged that Sanford kept billing despite warnings about a surgeon’s financial interest in implants and the need for his operations. Two Sanford surgeons brought the whistleblower case.
The alleged cost reached patients as well as taxpayers: unnecessary spinal operations, followed by government bills. The warnings connect what people inside the hospital knew to the claims it allegedly continued submitting.
OASIS Hospital in Phoenix and United Surgical Partners International agreed to pay a collective $5.6 million in a settlement announced in February 2026. The government alleged that, from 2011 through 2018, the hospital made improper financial contributions to a group referring patients to it. The alleged payments took the form of interest on convertible bonds issued to the group.
The Justice Department alleged violations of both the Stark Law and the Anti-Kickback Statute. In the government’s account, the payments looked like financing while the recipient group supplied referrals. United Surgical Partners International disclosed the arrangements after an internal review and independent investigation. The alleged bond-interest payments connect the financial arrangement to the hospital’s referral business.
The Oklahoma Center for Orthopaedic and Multi-Specialty Surgery, its management companies and Southwest Orthopaedic Specialists agreed to pay a collective $72.3 million in a July 2020 settlement. The allegations concerned improper hospital and physician-group financial relationships, including investment opportunities at four Texas surgery facilities.
The whistleblower’s complaint described physicians outside the group seeking permission to buy additional OCOM equity. It alleged that the group’s physicians controlled those opportunities:
The SOS Doctors would base these decisions on the non-SOS physician’s profitability (based on the volume and value of his referrals to OCOM).
In that allegation, the opportunity to invest was itself tied to the business the physician brought. The ownership decision belongs beside the distribution check when examining what the referring physician received.
Yes. A whistleblower can bring a False Claims Act case over a device company’s role in knowingly causing false claims, including claims submitted by a provider. In a Stark-based hospital case, we connect the financial arrangement and prohibited referral to the bill the hospital submitted.
A 2020 analysis in the Journal of Forensic and Investigative Accounting puts the payment request at the center of the inquiry:
The FCA does not attach liability to the underlying fraudulent activity or the government’s wrongful payment, but to the “claim for payment or approval.”
For an insider, that connection can join information held in different departments. Purchasing sees the supplier. Finance sees the physician’s compensation or investment payments. The operating record identifies the procedure and product. Billing supplies the claim. We bring those parts together around the conduct you know.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
We join the records that show the financial benefit, the physician’s decision, the hospital service and the claim, together with what the participants knew. Different records answer different parts of that inquiry:
Open Payments adds the manufacturer’s public description of a transfer. Comparing that description with the underlying transaction can expose a discrepancy. Internal payment and ownership records supply details beyond the public reporting categories.
A procurement employee may understand why the hospital changed suppliers. A compensation analyst may know why a payment changed. An operating-room representative may know whose products the surgeon insisted on using. We connect those observations to the financial documents and hospital claims with you.
If you know how a physician’s financial stake shaped hospital referrals or device purchasing, talk with our whistleblower experts about that arrangement. We work with you to build the case from the financial benefit through to the hospital claim, and bring in medical device whistleblower lawyers who understand physician ownership and hospital compensation. We stay beside you from the first conversation, pursuing the strongest case your evidence supports.